H.C. Wainwright analyst Yi Chen lowered the firm’s price target on Applied DNA Sciences to $4 from $5 and keeps a Buy rating on the shares post the fiscal Q3 report. The company’s testing revenue declined but its multiple segments provide growth opportunities, the analyst tells investors in a research note.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See today’s best-performing stocks on TipRanks >>
Read More on APDN: